Haematological challenges in cardiogenic shock

Area of Science:

• Cardiology
• Hematology
• Critical Care Medicine

Background:

• Cardiogenic shock (CS) is a critical condition with high mortality.
• Hematological complications, including coagulopathy and hemolysis, are frequent in CS patients.
• Percutaneous mechanical circulatory support (pMCS) use in CS exacerbates hematological challenges and worsens outcomes.

Approach:

• This review discusses the pathophysiology of hematological complications in CS.
• It examines management strategies for coagulopathies and hemolysis during CS and pMCS.
• The review proposes a management approach to restore hemostatic balance.

Key Points:

• Hematological complications significantly impact CS patient outcomes.
• pMCS in CS patients presents unique and complex hematological challenges.
• Effective management of hemostasis is crucial for improving survival rates.

Conclusions:

• Further research is needed to advance the management of hematological complications in CS.
• Developing targeted therapies for coagulopathy and hemolysis in CS is essential.
• A comprehensive strategy for managing hemostatic balance is vital for critically ill CS patients.